trending Market Intelligence /marketintelligence/en/news-insights/trending/qVo5gDO14WI5L7K7VdckVg2 content esgSubNav
In This List

Reata Pharmaceuticals withdraws $86.3M stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Reata Pharmaceuticals withdraws $86.3M stock offering

Reata Pharmaceuticals Inc. is withdrawing a registration statement for the sale of up to $86.3 million worth of class A common shares.

The shelf registration was filed earlier this month and is being withdrawn due to "unfavorable market conditions."